MAIA Biotechnology (MAIA) is trading down at $1.18 (-0.84%), as of the latest quote. It operates in the Health Care sector.
| FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | $0 | $0 | $0 | — |
| Operating income | −$7.79M | −$16.2M | −$20.2M | −$17.0M | −$24.3M |
| Net income | −$12.5M | −$16.2M | −$19.8M | −$23.3M | −$22.4M |
| EPS (diluted) | −$2.37 | −$1.75 | −$1.49 | −$1.05 | −$0.70 |
| Balance sheet | |||||
| Cash and equivalents | $0 | $0 | $0 | $0 | $0 |
| Total assets | $11.3M | $12.0M | $7.57M | $10.2M | $9.70M |
| Total liabilities | $2.15M | $3.51M | $7.09M | $6.52M | $7.33M |
| Shareholders' equity | $9.18M | $8.51M | $477.5K | $3.63M | $2.38M |
| Cash flow | |||||
| Operating cash flow | −$4.12M | −$12.1M | −$13.1M | −$15.7M | −$18.8M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$4.19M | −$5.00M | −$5.43M | −$5.17M | −$9.36M | −$4.32M | −$6.95M | −$8.32M |
| Net income | −$2.74M | −$3.57M | −$4.52M | −$5.35M | −$8.90M | −$3.63M | −$6.37M | −$7.94M |
| EPS (diluted) | −$0.11 | −$0.08 | −$0.16 | −$0.18 | −$0.27 | −$0.09 | −$0.14 | −$0.13 |
| Balance sheet | ||||||||
| Cash and equivalents | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $9.24M | $10.2M | $11.9M | $11.0M | $11.8M | $9.70M | $35.3M | $28.2M |
| Total liabilities | $7.62M | $6.52M | $6.92M | $7.17M | $11.7M | $7.33M | $7.56M | $7.57M |
| Shareholders' equity | $1.62M | $3.63M | $4.94M | $3.88M | $41.7K | $2.38M | $27.8M | $20.7M |
| Cash flow | ||||||||
| Operating cash flow | −$3.52M | −$3.91M | −$4.20M | −$4.14M | −$3.49M | −$7.02M | −$5.31M | −$6.75M |
From MAIA Biotechnology's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning MAIA Biotechnology in our feed yet.